
|Articles|January 1, 2004
- Volume 0 0
Report Cautions Use of Home Testing Kits
Advertisement
Report Cautions Use of HomeTesting Kits
A recent article in JohnsHopkins University?s Health After50 Medical Letter saidhome cholesterol testing kits can give inaccurate and incomplete results. In anexamination of 5 popular home cholesterol tests, the researchers discoveredthat 2 were inaccurate, 2 gave inadequate information, and all required asubstantial blood sample. The article recommends that patients notallow home testing kits to replace having their cholesteroltested by their physician.
Articles in this issue
almost 23 years ago
GER Is Common Among Children with Bronchial Asthmaalmost 23 years ago
Not All GERD Patients Are Alikealmost 23 years ago
Chronic Constipation Makes Headlinesalmost 23 years ago
Dyspepsia and Gastric Emptying in Diabeticsalmost 23 years ago
New Indications: 2003almost 23 years ago
Can You Read These Rxs? Answersalmost 23 years ago
Compounding Hotlinealmost 23 years ago
Sleep Apnea Is Tied to Depression?almost 23 years ago
Women Are Shortchanged on Getting Shut-Eyealmost 23 years ago
RLS Runs in the FamilyAdvertisement
Related to this article

Safe storage and responsible disposal help protect patients from accidental poisoning and drug misuse while keeping medications stable and effective.

Preserving patient access requires attention to the people, workflows, and financial structures behind the pharmacy counter, not just the number of open pharmacy locations.

The breakthrough is not only in cell and gene therapies but also in whether health care can translate them into practice.

Peer Reviewed
Semaglutide-Associated Sensory Skin Disturbance in Patients Without Diabetes Treated for Weight Loss
This case series describes 2 instances of cutaneous sensory disturbance during semaglutide therapy in patients without diabetes and discusses possible mechanisms as hypotheses requiring further investigation.

Pharmacists can help identify uncontrolled risk factors, review medications, and reinforce when patients should seek emergency care.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Giredestrant Plus Everolimus Wins FDA Approval in ESR1-Mutated Advanced Breast Cancer
2
FDA Grants Accelerated Approval to Neladalkib for Previously Treated ALK-Positive NSCLC
3
FDA Approves Secukinumab as First IL-17 Biologic for Polymyalgia Rheumatica
4
When Medicine Changes Faster Than Health Care: Preparing for a New Era
5



